Vertex Pharmaceuticals Inc. / MA, 10% Owner at CRISPR Therapeutics AG (CRSP), bought 80,396 shares at $24.89 ($2.0M) on 2018-12-26, disclosed to the SEC on 2018-12-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.89 | 12,737 | $317K | 15.8% |
| 2 | $24.89 | 12,737 | $317K | 15.8% |
| 3 | $24.95 | 27,461 | $685K | 34.2% |
| 4 | $24.95 | 27,461 | $685K | 34.2% |
| Total | $24.93 avg | 80,396 | $2.0M | 100% |